Literature DB >> 25967122

Podocyte p53 Limits the Severity of Experimental Alport Syndrome.

Ryosuke Fukuda1, Mary Ann Suico1, Yukari Kai1, Kohei Omachi1, Keishi Motomura1, Tomoaki Koga2, Yoshihiro Komohara3, Kosuke Koyama1, Tsubasa Yokota1, Manabu Taura1, Tsuyoshi Shuto1, Hirofumi Kai4.   

Abstract

Alport syndrome (AS) is one of the most common types of inherited nephritis caused by mutation in one of the glomerular basement membrane components. AS is characterized by proteinuria at early stage of the disease and glomerular hyperplastic phenotype and renal fibrosis at late stage. Here, we show that global deficiency of tumor suppressor p53 significantly accelerated AS progression in X-linked AS mice and decreased the lifespan of these mice. p53 protein expression was detected in 21-week-old wild-type mice but not in age-matched AS mice. Expression of proinflammatory cytokines and profibrotic genes was higher in p53(+/-) AS mice than in p53(+/+) AS mice. In vitro experiments revealed that p53 modulates podocyte migration and positively regulates the expression of podocyte-specific genes. We established podocyte-specific p53 (pod-p53)-deficient AS mice, and determined that pod-p53 deficiency enhanced the AS-induced renal dysfunction, foot process effacement, and alteration of gene-expression pattern in glomeruli. These results reveal a protective role of p53 in the progression of AS and in maintaining glomerular homeostasis by modulating the hyperplastic phenotype of podocytes in AS.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  Alport-s syndrome; mouse; p53; p53 knockout; podocyte; renal progression

Mesh:

Substances:

Year:  2015        PMID: 25967122      PMCID: PMC4696573          DOI: 10.1681/ASN.2014111109

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  52 in total

Review 1.  Podocyte differentiation and glomerulogenesis.

Authors:  Jordan A Kreidberg
Journal:  J Am Soc Nephrol       Date:  2003-03       Impact factor: 10.121

Review 2.  Cellular and molecular mechanisms of renal fibrosis.

Authors:  Youhua Liu
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

3.  Mdm2 is required for maintenance of the nephrogenic niche.

Authors:  Sylvia A Hilliard; Xiao Yao; Samir S El-Dahr
Journal:  Dev Biol       Date:  2014-01-17       Impact factor: 3.582

4.  Anoikis triggers Mdm2-dependent p53 degradation.

Authors:  Abhijit Ghosh; Tina Chunyuan Chen; Yvonne L Kapila
Journal:  Mol Cell Biochem       Date:  2010-06-26       Impact factor: 3.396

5.  Inflammation and p53: A Tale of Two Stresses.

Authors:  Andrei V Gudkov; Katerina V Gurova; Elena A Komarova
Journal:  Genes Cancer       Date:  2011-04

6.  Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins.

Authors:  Takehiko Wada; Jeffrey W Pippin; Caroline B Marshall; Sian V Griffin; Stuart J Shankland
Journal:  J Am Soc Nephrol       Date:  2005-06-29       Impact factor: 10.121

Review 7.  Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease.

Authors:  Douglas M Silverstein
Journal:  Pediatr Nephrol       Date:  2008-12-13       Impact factor: 3.714

8.  Silencing of p53 RNA through transarterial delivery ameliorates renal tubular injury and downregulates GSK-3β expression after ischemia-reperfusion injury.

Authors:  Takayuki Fujino; Sharifi Muhib; Nobuyuki Sato; Naoyuki Hasebe
Journal:  Am J Physiol Renal Physiol       Date:  2013-10-09

Review 9.  FAK and p53 protein interactions.

Authors:  Vita M Golubovskaya; William G Cance
Journal:  Anticancer Agents Med Chem       Date:  2011-09       Impact factor: 2.505

10.  Mild electrical stimulation and heat shock ameliorates progressive proteinuria and renal inflammation in mouse model of Alport syndrome.

Authors:  Tomoaki Koga; Yukari Kai; Ryosuke Fukuda; Saori Morino-Koga; Mary Ann Suico; Kosuke Koyama; Takashi Sato; Tsuyoshi Shuto; Hirofumi Kai
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

View more
  14 in total

1.  Endothelin A receptor activation on mesangial cells initiates Alport glomerular disease.

Authors:  Brianna Dufek; Daniel T Meehan; Duane Delimont; Linda Cheung; Michael Anne Gratton; Grady Phillips; Wenping Song; Shiguang Liu; Dominic Cosgrove
Journal:  Kidney Int       Date:  2016-04-27       Impact factor: 10.612

2.  Pathogenicity of a Human Laminin β2 Mutation Revealed in Models of Alport Syndrome.

Authors:  Steven D Funk; Raymond H Bayer; Andrew F Malone; Karen K McKee; Peter D Yurchenco; Jeffrey H Miner
Journal:  J Am Soc Nephrol       Date:  2017-12-20       Impact factor: 10.121

3.  Long-term treatment with EGFR inhibitor erlotinib attenuates renal inflammatory cytokines but not nephropathy in Alport syndrome mouse model.

Authors:  Kohei Omachi; Rui Miyakita; Ryosuke Fukuda; Yukari Kai; Mary Ann Suico; Tsubasa Yokota; Misato Kamura; Tsuyoshi Shuto; Hirofumi Kai
Journal:  Clin Exp Nephrol       Date:  2017-02-08       Impact factor: 2.801

Review 4.  Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome.

Authors:  Dominic Cosgrove; Shiguang Liu
Journal:  Matrix Biol       Date:  2016-08-27       Impact factor: 11.583

5.  C-X-C Chemokine Receptor Type 4 Plays a Crucial Role in Mediating Oxidative Stress-Induced Podocyte Injury.

Authors:  Hongyan Mo; Qinyu Wu; Jinhua Miao; Congwei Luo; Xue Hong; Yongping Wang; Lan Tang; Fan Fan Hou; Youhua Liu; Lili Zhou
Journal:  Antioxid Redox Signal       Date:  2017-03-28       Impact factor: 8.401

6.  Bromide supplementation exacerbated the renal dysfunction, injury and fibrosis in a mouse model of Alport syndrome.

Authors:  Tsubasa Yokota; Kohei Omachi; Mary Ann Suico; Haruka Kojima; Misato Kamura; Keisuke Teramoto; Shota Kaseda; Jun Kuwazuru; Tsuyoshi Shuto; Hirofumi Kai
Journal:  PLoS One       Date:  2017-09-05       Impact factor: 3.240

7.  Autophagy is involved in mouse kidney development and podocyte differentiation regulated by Notch signalling.

Authors:  Chuyue Zhang; Wen Li; Junkai Wen; Zhuo Yang
Journal:  J Cell Mol Med       Date:  2017-02-03       Impact factor: 5.310

8.  p53 induces miR199a-3p to suppress SOCS7 for STAT3 activation and renal fibrosis in UUO.

Authors:  Ruhao Yang; Xuan Xu; Huiling Li; Jinwen Chen; Xudong Xiang; Zheng Dong; Dongshan Zhang
Journal:  Sci Rep       Date:  2017-02-27       Impact factor: 4.379

9.  A novel condition of mild electrical stimulation exerts immunosuppression via hydrogen peroxide production that controls multiple signaling pathway.

Authors:  Mariam Piruzyan; Ihori Shitanda; Yuichiro Shimauchi; Go Okita; Yu Tsurekawa; Masataka Moriuchi; Yoshio Nakano; Keisuke Teramoto; Mary Ann Suico; Tsuyoshi Shuto; Hirofumi Kai
Journal:  PLoS One       Date:  2020-06-22       Impact factor: 3.240

Review 10.  Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis.

Authors:  Sun-Wei Guo
Journal:  Reprod Med Biol       Date:  2018-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.